Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub

Therapeutic Classification

androgen Registry

Clinical reference for androgen medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (androgen)

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.

MedicationTherapeutic ClassMaternal Safety

ANDRODERM

Comprehensive clinical and safety monograph for ANDRODERM (ANDRODERM).

Androgen

caution

ANDROGEL

Comprehensive clinical and safety monograph for ANDROGEL (ANDROGEL).

Androgen

caution

ANDROID 10

Comprehensive clinical and safety monograph for ANDROID 10 (ANDROID 10).

Androgen

caution

ANDROID 25

Comprehensive clinical and safety monograph for ANDROID 25 (ANDROID 25).

Androgen

caution

ANDROID 5

Comprehensive clinical and safety monograph for ANDROID 5 (ANDROID 5).

Androgen

caution

ANDROID-F

Comprehensive clinical and safety monograph for ANDROID-F (ANDROID-F).

Androgen/Estrogen Combination

caution

APALUTAMIDE

Comprehensive clinical and safety monograph for APALUTAMIDE (APALUTAMIDE).

Androgen Receptor Inhibitor

caution

AVEED

Comprehensive clinical and safety monograph for AVEED (AVEED).

Androgen (Testosterone Replacement)

caution

AXIRON

Comprehensive clinical and safety monograph for AXIRON (AXIRON).

Androgen

caution

BICALUTAMIDE

Comprehensive clinical and safety monograph for BICALUTAMIDE (BICALUTAMIDE).

Antiandrogen Antineoplastic

caution

CASODEX

Comprehensive clinical and safety monograph for CASODEX (CASODEX).

Antiandrogen

caution

DANAZOL

Comprehensive clinical and safety monograph for DANAZOL (DANAZOL).

Androgen/Antigonadotropin

caution

DANOCRINE

Comprehensive clinical and safety monograph for DANOCRINE (DANOCRINE).

Androgen/Antigonadotropin

caution

DANZITEN

Comprehensive clinical and safety monograph for DANZITEN (DANZITEN).

Androgen/Antigonadotropin

caution

DELATESTRYL

Comprehensive clinical and safety monograph for DELATESTRYL (DELATESTRYL).

Androgen

caution

DEPO-TESTOSTERONE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

DURABOLIN

Comprehensive clinical and safety monograph for DURABOLIN (DURABOLIN).

Anabolic Androgenic Steroid

caution

ENOBY

Comprehensive clinical and safety monograph for ENOBY (ENOBY).

Selective Androgen Receptor Modulator

caution

ENZALUTAMIDE

Strong CYP2C8 inhibitors may increase levels and inducers may decrease levels Can cause seizures and posterior reversible encephalopathy syndrome (PRES).

Androgen Receptor Inhibitor

avoid

ERLEADA

Comprehensive clinical and safety monograph for ERLEADA (ERLEADA).

Androgen Receptor Inhibitor Antineoplastic

caution

EULEXIN

Comprehensive clinical and safety monograph for EULEXIN (EULEXIN).

Antiandrogen

caution

FLUOXYMESTERONE

Comprehensive clinical and safety monograph for FLUOXYMESTERONE (FLUOXYMESTERONE).

Androgen

caution

FLUTAMIDE

Warfarin metabolism is inhibited increasing INR Can cause hepatotoxicity and gynecomastia.

Antiandrogen

avoid

FORTESTA

Comprehensive clinical and safety monograph for FORTESTA (FORTESTA).

Androgen

caution

H.R.-50

Comprehensive clinical and safety monograph for H.R.-50 (H.R.-50).

Androgen

caution

HALOTESTIN

Comprehensive clinical and safety monograph for HALOTESTIN (HALOTESTIN).

Androgen

caution

JATENZO

Comprehensive clinical and safety monograph for JATENZO (JATENZO).

Androgen Replacement Therapy

caution

KYZATREX

Comprehensive clinical and safety monograph for KYZATREX (KYZATREX).

Androgen

caution

METANDREN

Comprehensive clinical and safety monograph for METANDREN (METANDREN).

Androgen

caution

METHYLTESTOSTERONE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

NATESTO

Comprehensive clinical and safety monograph for NATESTO (NATESTO).

Androgen

caution

NILANDRON

Comprehensive clinical and safety monograph for NILANDRON (NILANDRON).

Antiandrogen

caution

NILUTAMIDE

Comprehensive clinical and safety monograph for NILUTAMIDE (NILUTAMIDE).

Antiandrogen

caution

NUBEQA

Comprehensive clinical and safety monograph for NUBEQA (NUBEQA).

Androgen Receptor Inhibitor

caution

ORA-TESTRYL

Comprehensive clinical and safety monograph for ORA-TESTRYL (ORA-TESTRYL).

Androgen

caution

ORETON

Comprehensive clinical and safety monograph for ORETON (ORETON).

Androgen

caution

ORETON METHYL

Comprehensive clinical and safety monograph for ORETON METHYL (ORETON METHYL).

Androgen

caution

TESTIM

Comprehensive clinical and safety monograph for TESTIM (TESTIM).

Androgen

caution

TESTODERM

Comprehensive clinical and safety monograph for TESTODERM (TESTODERM).

Androgen

caution

TESTODERM TTS

Comprehensive clinical and safety monograph for TESTODERM TTS (TESTODERM TTS).

Androgen

caution

TESTOPEL

Comprehensive clinical and safety monograph for TESTOPEL (TESTOPEL).

Androgen

caution

TESTOSTERONE CYPIONATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

TESTOSTERONE ENANTHATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

TESTOSTERONE PROPIONATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

TESTOSTERONE UNDECANOATE

Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.

Androgen

avoid

TESTRED

Comprehensive clinical and safety monograph for TESTRED (TESTRED).

Androgen

caution

TESULOID

Comprehensive clinical and safety monograph for TESULOID (TESULOID).

Androgen

caution

TLANDO

Comprehensive clinical and safety monograph for TLANDO (TLANDO).

Androgen/hormone replacement

caution

TREST

Comprehensive clinical and safety monograph for TREST (TREST).

Androgen

caution

VIRILON

Comprehensive clinical and safety monograph for VIRILON (VIRILON).

Androgen

caution

VOGELXO

Comprehensive clinical and safety monograph for VOGELXO (VOGELXO).

Androgen Replacement

caution

WINLEVI

Comprehensive clinical and safety monograph for WINLEVI (WINLEVI).

Topical Androgen Receptor Inhibitor

caution

XYOSTED (AUTOINJECTOR)

Comprehensive clinical and safety monograph for XYOSTED (AUTOINJECTOR) (XYOSTED (AUTOINJECTOR)).

Androgen Replacement

caution

YONSA

Comprehensive clinical and safety monograph for YONSA (YONSA).

Androgen Biosynthesis Inhibitor

caution